<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20180521039762N5</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-02-05</date_registration>
      <primary_sponsor>Payame Noor University</primary_sponsor>
      <public_title>Effect of Corrective Exercises on Knee Valgus and Gluteal Muscle Function in Women</public_title>
      <acronym></acronym>
      <scientific_title>The Effects of Comprehensive and Localized Corrective Exercises on Knee Valgus and Gluteal Muscle Strength and Endurance in Women with Gluteal Muscle Dysfunction</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-02-06</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/88664</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: After the initial assessment and screening for inclusion and exclusion criteria, eligible participants will enter the randomization phase. Randomization in this study will be performed as simple randomization with an individual randomization unit. The random sequence will be generated using the Random function in Microsoft Excel. Based on this sequence, participants will be randomly assigned to three equal groups: the local corrective exercise group, the comprehensive corrective exercise group, and the control group, Blinding description: Participants will be aware of their group assignment because the study objectives and interventions are explained to them, and blinding participants is not ethically possible. However, individuals involved in data collection and outcome assessment, including measurement assessors and the data analyst, will be blinded to group assignments. The principal investigator and healthcare personnel (physicians, physiotherapists, or trainers) who interact directly with participants will be aware of the group allocation. The Data Safety and Monitoring Committee and personnel preparing the manuscript will also remain blinded to group assignments. This design minimizes potential bias during data collection and analysis.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Gluteal muscle dysfunction.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1 – Local corrective exercise: Participants will follow a 12-week program of exercises focused on gluteal muscles. Sessions will be conducted three times per week under researcher supervision. Intervention 2: Intervention group 2 – Comprehensive corrective exercise: Participants will follow a 12-week program of exercises targeting the lower limbs and gluteal muscles. Sessions will be conducted three times per week under researcher supervision. Intervention 3: Control group: Participants will continue their usual daily activities without receiving any specific exercise program.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Individual participant data (IPD) from the study, after de-identification to ensure participant privacy, will be shared upon reasonable request with researchers for secondary analyses related to gluteal muscle function and knee valgus. The data will include primary and secondary outcomes, demographic information, and relevant clinical measures.

When:
Access to the data and documents will begin after the completion of the study and the publication of the main results. Data preparation will include de-identification of participants’ information. Access is expected to be available to interested researchers six months after publication of the results and will continue indefinitely.

To whom:
Access to the data and documents will be granted to researchers interested in scientific and secondary analyses. Requests for access should include a description of the intended research purpose and type of analysis. The data will not be available for direct commercial use and will be shared only for legitimate scientific research purposes.

Conditions:
The study data and documents may be used solely for scientific research and secondary analyses related to gluteal muscle function and knee valgus. Applicants must provide a written description of the research purpose and proposed analyses. Direct commercial use of the data is not permitted. Individual participant data will be de-identified to protect privacy. Applicants are required to use the data only for the approved purposes and must not publish results without permission.

Where to obtain:
Applicants requesting access to study data and documents should contact the Principal Investigator:
Name: Dr. Afshin Moghadasi
Department: Department of Sports Injury and Corrective Exercises
Institution: Payame Noor University (PNU)
P.O. Box: 19395-4697, Tehran, Iran
Email: moghadasi@pnu.ac.ir
Phone: +98 918 943 2264
Please include in your email or correspondence a description of the research purpose and proposed analyses so that your request can be evaluated.

How to obtain:
1. The applicant should submit a written request via email to the Principal Investigator.
2. The request must clearly describe the research purpose, proposed analyses, and the specific data or documents needed.
3. The Principal Investigator will review the request and, if approved, a Data Use Agreement outlining the terms of use will be sent to the applicant.
4. After signing and returning the agreement, the de-identified data and documents will be prepared and provided to the applicant.
5. The entire process typically takes 2 to 4 weeks after a complete and valid request, depending on the volume of data and complexity of the request.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Afshin Moghadasi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Payame Noor University, Nakhl St, Artesh Blvd, Tehran, Tehran Province, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>193954697</zip>
        <telephone>+98 21 2332 0000</telephone>
        <email>moghadasi@pnu.ac.ir</email>
        <affiliation>Payame Noor University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Afshin Moghadasi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Payame Noor University, Nakhl St, Artesh Blvd, Tehran, Tehran Province, Iran</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>193954697</zip>
        <telephone>+98 21 2332 0000</telephone>
        <email>moghadasi@pnu.ac.ir</email>
        <affiliation>Payame Noor University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Presence of gluteal muscle dysfunction
Age range between 18 and 50 years
Female gender
Physical inactivity and no regular exercise participation during the past 6 months
No medical contraindication for participation in exercise programs</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>History of serious injury or surgery in the lumbopelvic region or lower limbs
Presence of progressive neuromuscular diseases
Presence of severe joint disorders such as hip or knee osteoarthritis
Intervertebral disc herniation or spondylolisthesis
Use of assistive walking devices such as a cane</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1 – Local corrective exercise: Participants will follow a 12-week program of exercises focused on gluteal muscles. Sessions will be conducted three times per week under researcher supervision.</i_keyword>
      <i_keyword>Intervention group 2 – Comprehensive corrective exercise: Participants will follow a 12-week program of exercises targeting the lower limbs and gluteal muscles. Sessions will be conducted three times per week under researcher supervision.</i_keyword>
      <i_keyword>Control group: Participants will continue their usual daily activities without receiving any specific exercise program.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>- Gluteal muscle strength (abduction, external rotation, hip extension) will be measured using a dynamometer. Timepoint: Before the intervention and after the 12-week exercise program. Method of measurement: Dynamometer.</prim_outcome>
      <prim_outcome>Gluteal muscle endurance will be measured as the single-leg bridge hold time. Timepoint: Before the intervention and after the 12-week exercise program. Method of measurement: Timer to measure the duration of the single-leg bridge hold.</prim_outcome>
      <prim_outcome>Static and dynamic knee valgus will be assessed by measuring Q-angle and femur–tibia angle during standing and single-leg squat. Timepoint: Before the intervention and after the 12-week exercise program. Method of measurement: Goniometer or video analysis software to measure angles.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Hip joint flexibility will be assessed by measuring range of motion in abduction and external rotation. Timepoint: Before the exercise program and after the 12-week intervention. Method of measurement: Goniometer to measure joint angles.</sec_outcome>
      <sec_outcome>Static balance will be assessed using the single-leg stance test measuring the duration of balance. Timepoint: Before the exercise program and after the 12-week intervention. Method of measurement: Timer to record single-leg stance duration.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Payame Noor University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-12-20</approval_date>
        <contact_name>Research Ethics Committees of Payame Noor University</contact_name>
        <contact_address>Payame Noor University, Nakhl St., Artesh Blvd., Tehran, Iran Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
